- Germany rouses Eisai's fury with second Fycompa rejection
- New Takeda moves signal emerging markets intent
- Outrage at Cancer Drugs Fund casualty list
- Indian efforts on pricing of patented drugs gather steam?
COMMENT Other Informa Comment
- The EMA at 20: Guido Rasi looks at how the EU regulatory landscape might change over the next decade
- Scrip 100: Chugai USA's new CMO is a Man for All Regions
JOB OF THE WEEK Promote your job vacancy